PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Fourth Quarter and Fiscal Year 2020 Results
- Fourth quarter net product sales of
$2.6 million , rebounding 20% from the third quarter - Fourth quarter net loss of
$10.4 million , or ($0.54 ) per share, on a GAAP basis; net loss of$0.3 million , or ($0.02 ) per share, on a non-GAAP basis - Adjusted EBITDA of
$0.2 million for the fourth quarter;$4.1 million for the fiscal year
Fourth Quarter 2020 Financial Results
Total revenue was
Net loss attributable to
Full Year 2020 Financial Results
Total revenue was
Net loss attributable to
See reconciliation tables below for non-GAAP metrics. These non-GAAP metrics may be inconsistent with similar measures presented by other companies and should only be used in conjunction with our results reported according to
The Company's balance sheet at
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Condensed Consolidated Balance Sheets | ||||||||
(in thousands, except share and per share data) | ||||||||
(Unaudited) | ||||||||
Assets | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 4,957 | $ | 4,641 | ||||
Accounts receivable, net | 8,889 | 10,622 | ||||||
Inventory | 1,216 | 899 | ||||||
Prepaid expenses and other current assets | 1,085 | 1,404 | ||||||
Total current assets | 16,147 | 17,566 | ||||||
Property and equipment, net | 3,367 | 3,666 | ||||||
Operating lease right-of-use assets | 8,668 | 9,250 | ||||||
Trademarks and other intangibles, net | 93,535 | 111,095 | ||||||
Restricted cash | 1,109 | 1,109 | ||||||
Other assets | 228 | 505 | ||||||
Total non-current assets | 106,907 | 125,625 | ||||||
Total Assets | $ | 123,054 | $ | 143,191 | ||||
Liabilities and Equity | ||||||||
Current Liabilities: | ||||||||
Accounts payable, accrued expenses and other current liabilities | $ | 4,442 | $ | 4,391 | ||||
Accrued payroll | 973 | 1,444 | ||||||
Current portion of operating lease obligation | 2,101 | 1,752 | ||||||
Current portion of long-term debt | 2,800 | 2,250 | ||||||
Total current liabilities | 10,316 | 9,837 | ||||||
Long-Term Liabilities: | ||||||||
Long-term portion of operating lease obligation | 8,469 | 9,773 | ||||||
Long-term debt, less current portion | 13,838 | 16,571 | ||||||
Contingent obligation | 900 | 900 | ||||||
Deferred tax liabilities, net | 3,052 | 7,434 | ||||||
Other long-term liabilities | 224 | 224 | ||||||
Total long-term liabilities | 26,483 | 34,902 | ||||||
Total Liabilities | 36,799 | 44,739 | ||||||
Commitments and Contingencies | ||||||||
Equity: | ||||||||
Preferred stock, |
- | - | ||||||
Common stock, |
19 | 19 | ||||||
Paid-in capital | 102,324 | 101,736 | ||||||
Accumulated deficit | (16,595 | ) | (3,659 | ) | ||||
85,748 | 98,096 | |||||||
Noncontrolling interest | 507 | 356 | ||||||
Total Equity | 86,255 | 98,452 | ||||||
Total Liabilities and Equity | $ | 123,054 | $ | 143,191 | ||||
Unaudited Condensed Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except share and per share data) | ||||||||||||||||
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Revenues | ||||||||||||||||
Net licensing revenue | $ | 4,877 | $ | 5,341 | $ | 20,255 | $ | 26,435 | ||||||||
Net sales | 2,603 | 6,015 | 9,193 | 15,292 | ||||||||||||
Net revenue | 7,480 | 11,356 | 29,448 | 41,727 | ||||||||||||
Cost of goods sold (sales) | 1,533 | 3,723 | 5,456 | 10,272 | ||||||||||||
Gross profit | 5,947 | 7,633 | 23,992 | 31,455 | ||||||||||||
Operating costs and expenses | ||||||||||||||||
Salaries, benefits and employment taxes | 3,263 | 3,796 | 13,061 | 15,834 | ||||||||||||
Other design and marketing costs | 998 | 812 | 3,334 | 3,164 | ||||||||||||
Other selling, general and administrative expenses | 1,540 | 1,538 | 6,567 | 5,552 | ||||||||||||
Costs (recovery of costs) in connection with potential acquisition | 52 | 1,059 | (158 | ) | 1,290 | |||||||||||
Stock-based compensation | 70 | 199 | 850 | 976 | ||||||||||||
Depreciation and amortization | 1,428 | 963 | 5,497 | 3,902 | ||||||||||||
Government assistance - Paycheck Protection Program | 0 | - | (1,816 | ) | - | |||||||||||
Asset impairments | 13,000 | 6,200 | 13,113 | 6,200 | ||||||||||||
Total operating costs and expenses | 20,351 | 14,567 | 40,448 | 36,918 | ||||||||||||
Other income | - | - | 46 | 2,850 | ||||||||||||
Operating loss | (14,404 | ) | (6,934 | ) | (16,410 | ) | (2,613 | ) | ||||||||
Interest and finance expense | ||||||||||||||||
Interest expense and other finance charges | 296 | 317 | 1,193 | 1,285 | ||||||||||||
Loss on extinguishment of debt | - | - | - | 189 | ||||||||||||
Total interest and finance expense | 296 | 317 | 1,193 | 1,474 | ||||||||||||
Loss before income taxes | (14,700 | ) | (7,251 | ) | (17,603 | ) | (4,087 | ) | ||||||||
Income tax benefit | (4,249 | ) | (1,922 | ) | (4,518 | ) | (642 | ) | ||||||||
Net loss | (10,451 | ) | (5,329 | ) | (13,085 | ) | (3,445 | ) | ||||||||
Less: Net loss attributable to noncontrolling interest | (54 | ) | (19 | ) | (149 | ) | (19 | ) | ||||||||
Net loss attributable to |
$ | (10,397 | ) | $ | (5,310 | ) | $ | (12,936 | ) | $ | (3,426 | ) | ||||
Loss per share attributed to |
||||||||||||||||
Basic net loss per share: | $ | (0.54 | ) | $ | (0.28 | ) | $ | (0.68 | ) | $ | (0.18 | ) | ||||
Diluted net loss per share: | $ | (0.54 | ) | $ | (0.28 | ) | $ | (0.68 | ) | $ | (0.18 | ) | ||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic weighted average common shares outstanding | 19,233,633 | 18,911,760 | 19,117,460 | 18,857,657 | ||||||||||||
Diluted weighted average common shares outstanding | 19,233,633 | 18,911,760 | 19,117,460 | 18,857,657 | ||||||||||||
Unaudited Condensed Consolidated Statements of Cash Flows | ||||||||
(in thousands) | ||||||||
For the Twelve Months Ended | ||||||||
2020 | 2019 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (13,085 | ) | $ | (3,445 | ) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
Depreciation and amortization expense | 5,497 | 3,902 | ||||||
Asset impairment charges | 13,113 | 6,200 | ||||||
Amortization of deferred finance costs | 95 | 146 | ||||||
Stock-based compensation | 850 | 976 | ||||||
Amortization of note discount | 16 | |||||||
Allowance for doubtful accounts | 1,042 | (50 | ) | |||||
Loss on extinguishment of debt | - | 189 | ||||||
Deferred income tax benefit | (4,382 | ) | (705 | ) | ||||
Net gain on sale of assets | (46 | ) | ||||||
Gain on reduction of contingent obligation | - | (2,850 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | 691 | 438 | ||||||
Inventory | (317 | ) | 1,089 | |||||
Prepaid expenses and other assets | 597 | (59 | ) | |||||
Accounts payable, accrued expenses and other current liabilities | (496 | ) | (1,720 | ) | ||||
Cash paid in excess of rent expense | (374 | ) | (431 | ) | ||||
Other liabilities | - | (196 | ) | |||||
Net cash provided by operating activities | 3,185 | 3,500 | ||||||
Cash flows from investing activities | ||||||||
Cash consideration for asset acquisition of the Halston Heritage assets | - | (8,830 | ) | |||||
Investment in |
- | (375 | ) | |||||
Net proceeds from sale of assets | 46 | - | ||||||
Purchase of property and equipment | (748 | ) | (1,133 | ) | ||||
Net cash used in investing activities | (702 | ) | (10,338 | ) | ||||
Cash flows from financing activities | ||||||||
Shares repurchased including vested restricted stock in exchange for withholding taxes | (190 | ) | (174 | ) | ||||
Cash contribution from non-controlling interest | 300 | |||||||
Payment of deferred finance costs | (27 | ) | (315 | ) | ||||
Proceeds from long-term debt | - | 7,500 | ||||||
Payment of long-term debt | (2,250 | ) | (4,742 | ) | ||||
Net cash (used in) provided by financing activities | (2,167 | ) | 2,269 | |||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 316 | (4,569 | ) | |||||
Cash, cash equivalents, and restricted cash at beginning of period | 5,750 | 10,319 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 6,066 | $ | 5,750 | ||||
Reconciliation to amounts on consolidated balance sheets: | ||||||||
Cash and cash equivalents | 4,957 | $ | 4,641 | |||||
Restricted cash | 1,109 | 1,109 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 6,066 | $ | 5,750 | ||||
Supplemental disclosure of non-cash activities: | ||||||||
Operating lease right-of-use asset | $ | 797 | $ | 10,409 | ||||
Operating lease obligation | $ | 797 | $ | 13,210 | ||||
Accrued rent offset to operating lease right-of-use assets | $ | - | $ | 2,801 | ||||
Settlement of seller note through offset to receivable | $ | - | $ | 600 | ||||
Settlement of contingent obligation through offset to note receivable | $ | $ | 100 | |||||
Issuance of common stock in connection with |
$ | - | $ | 1,058 | ||||
Contingent obligation related to acquisition of |
$ | - | $ | 900 | ||||
Liability for equity-based bonuses | $ | 71 | $ | 220 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid during the period for income taxes | $ | 58 | $ | 136 | ||||
Cash paid during the period for interest | $ | 1,128 | $ | 1,176 | ||||
($ in thousands) | Three Months Ended | Twelve Months Ended | |||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (10,397 | ) | (5,329 | ) | $ | (12,936 | ) | $ | (3,426 | ) | ||||
Amortization of trademarks | 1,109 | 796 | 4,432 | 3,105 | |||||||||||
Non-cash interest and finance expense | - | - | - | 16 | |||||||||||
Stock-based compensation | 70 | 199 | 850 | 976 | |||||||||||
Loss on extinguishment of debt | - | - | - | 189 | |||||||||||
Costs (recovery of costs) in connection with potential acquisition | 52 | 1,059 | (158 | ) | 1,290 | ||||||||||
Certain adjustments to allowance for doubtful accounts | - | - | 971 | - | |||||||||||
Asset impairments | 13,000 | 6,200 | 13,113 | 6,200 | |||||||||||
Gain on sale of assets | - | - | (46 | ) | - | ||||||||||
Gain on reduction of contingent obligation | - | - | - | (2,850 | ) | ||||||||||
Deferred income tax benefit | (4,113 | ) | (1,985 | ) | (4,382 | ) | (705 | ) | |||||||
Non-GAAP net income | $ | (279 | ) | $ | 940 | $ | 1,844 | $ | 4,795 | ||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Diluted loss per share attributable to |
$ | (0.54 | ) | $ | (0.28 | ) | $ | (0.68 | ) | $ | (0.18 | ) | |||
Amortization of trademarks | 0.06 | 0.04 | 0.23 | 0.16 | |||||||||||
Non-cash interest and finance expense | - | - | - | - | |||||||||||
Stock-based compensation | - | 0.01 | 0.04 | 0.05 | |||||||||||
Loss on extinguishment of debt | - | - | - | 0.01 | |||||||||||
Costs (recovery of costs) in connection with potential acquisition | - | 0.05 | (0.01 | ) | 0.07 | ||||||||||
Certain adjustments to allowance for doubtful accounts | - | - | 0.05 | - | |||||||||||
Asset impairments | 0.67 | 0.33 | 0.69 | 0.33 | |||||||||||
Gain on sale of assets | - | - | - | - | |||||||||||
Gain on reduction of contingent obligation | - | - | - | (0.15 | ) | ||||||||||
Deferred income tax benefit | (0.21 | ) | (0.10 | ) | (0.22 | ) | (0.04 | ) | |||||||
Non-GAAP diluted EPS | $ | (0.02 | ) | $ | 0.05 | $ | 0.10 | $ | 0.25 | ||||||
Non-GAAP weighted average diluted shares | 19,323,078 | 18,913,476 | 19,152,569 | 18,858,379 | |||||||||||
($ in thousands) | Three Months Ended | Twelve Months Ended | |||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (10,397 | ) | $ | (5,310 | ) | $ | (12,936 | ) | $ | (3,426 | ) | |||
Depreciation and amortization | 1,428 | 963 | 5,497 | 3,902 | |||||||||||
Interest and finance expense | 296 | 317 | 1,193 | 1,474 | |||||||||||
Income tax benefit | (4,249 | ) | (1,922 | ) | (4,518 | ) | (642 | ) | |||||||
State and local franchise taxes | 21 | 38 | 145 | 197 | |||||||||||
Stock-based compensation | 70 | 199 | 850 | 976 | |||||||||||
Costs (recovery of costs) in connection with potential acquisition | 52 | 1,059 | (158 | ) | 1,290 | ||||||||||
Certain adjustments to allowance for doubtful accounts | - | - | 971 | - | |||||||||||
Asset impairments | 13,000 | 6,200 | 13,113 | 6,200 | |||||||||||
Gain on sale of assets | - | - | (46 | ) | - | ||||||||||
Gain on reduction of contingent obligation | - | - | - | (2,850 | ) | ||||||||||
Adjusted EBITDA | $ | 221 | $ | 1,544 | $ | 4,111 | $ | 7,121 | |||||||
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results.
Non-GAAP net income for the current year includes adjustments related to allowances for doubtful accounts for account debtors that have filed for bankruptcy protection triggered by the impact of COVID-19. In addition, the Company incurred certain costs during the year which it could have eliminated but elected not to do so in light of
Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under the Xcel Term Loan. Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
Source: Xcel Brands, Inc